TScan Therapeutics TCRX Cash Flow Statement (2020-2026)

NASDAQ TCRX
$0.78 +0.03 (+4.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-25.29M-14.89M-16.16M-15.10M-16.25M-19.55M-22.56M-24.05M-23.00M-20.26M-30.14M-31.66M-29.89M-46.73M-36.98M-36.95M-35.71M-31.84M-28.67M-30.36M
Depreciation and Depletion (Quarter)
1.06M1.14M1.20M1.21M1.25M1.48M1.50M1.30M1.29M1.28M1.25M1.12M1.03M0.71M0.68M0.70M0.77M0.72M0.69M0.70M
Share-based Compensation (Quarter)
10.60M0.78M0.98M1.02M1.25M1.30M1.15M1.22M1.34M1.50M1.98M2.33M2.52M2.71M3.41M3.27M3.01M2.01M2.46M2.36M
Cash from Operations (Quarter)
-13.64M-14.38M-20.12M-13.37M-17.00M-16.01M-23.59M-22.02M8.02M-23.77M-29.27M-26.23M-27.92M-27.41M-37.59M-33.27M-32.46M-32.00M-24.28M-27.54M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
1.06M1.14M1.20M1.21M1.25M1.48M1.50M1.30M1.29M1.28M1.25M1.12M1.03M0.71M0.68M0.70M0.77M0.72M0.69M0.70M
Change in Working Capital
Change in Account Payables (Quarter)
0.88M-2.46M0.82M0.41M-1.12M0.41M0.49M0.37M-0.27M-0.64M-0.41M0.40M1.02M0.98M0.56M-0.43M1.93M-5.07M1.04M0.84M
Change in Accured Expenses (Quarter)
1.71M1.85M-2.80M0.61M1.60M1.32M0.74M0.78M1.02M1.31M-1.60M1.95M0.53M3.66M-5.41M2.67M-1.11M-3.38M0.90M-0.74M
Other Working Capital Changes (Quarter)
0.82M-0.44M0.66M-1.15M0.73M0.17M1.18M-2.91M0.69M0.05M-0.26M0.01M1.17M-0.39M0.52M-0.04M-0.87M0.90M-0.13M-0.48M
Investing Activities
Capital Expenditures (Quarter)
7.35M2.21M0.53M1.89M-1.85M-0.13M0.02M0.06M0.26M-0.04M0.70M0.86M1.37M0.89M1.53M-0.60M-0.88M-0.04M0.07M0.49M
Change in Acquisitions & Divestments (Quarter)
45.65M15.50M56.00M75.51M76.00M76.25M34.00M15.00M
Cash from Investing Activities (Quarter)
-0.85M-2.21M-0.53M-1.89M-0.42M-1.38M-0.84M-0.42M-61.41M1.91M36.16M-33.72M-82.35M27.29M13.53M48.44M32.58M14.83M-0.07M-0.47M
Financing Activities
Other financing activities (Quarter)
0.00M0.12M0.09M0.03M0.01M0.07M-0.08M-91.61M0.26M0.18M127.83M-126.56M0.12M0.07M-0.01M0.01M
Cash from Financing Activities (Quarter)
90.61M0.12M0.09M0.03M29.13M0.11M-0.25M0.02M0.26M161.59M1.23M45.69M-0.53M0.12M0.07M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
0.19M-0.19M
Additional items
Change in Cash (Quarter)
76.11M-16.47M-20.57M-15.23M11.70M-17.28M-24.43M113.23M-53.65M-21.83M7.15M101.65M-109.04M45.57M-24.58M15.29M0.11M-17.10M-24.35M-27.90M
Free Cash Flow (Quarter)
-20.99M-16.59M-20.66M-15.26M-15.15M-15.88M-23.61M-22.09M7.76M-23.72M-29.97M-27.09M-29.29M-28.30M-39.12M-32.66M-31.59M-31.96M-24.35M-28.03M
Net Cash Flow (Quarter)
76.11M-16.47M-20.57M-15.23M11.70M-17.28M-24.43M-22.44M-53.65M-21.83M7.15M101.65M-109.04M45.57M-24.58M15.29M0.11M-17.10M-24.35M-28.00M